- Previous Close
4,085.00 - Open
4,120.00 - Bid 4,080.00 x --
- Ask 4,085.00 x --
- Day's Range
4,055.00 - 4,120.00 - 52 Week Range
4,015.00 - 9,300.00 - Volume
2,197 - Avg. Volume
32,124 - Market Cap (intraday)
49.122B - Beta (5Y Monthly) 0.11
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Mar 17, 2025 - Mar 21, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.
www.telcon.co.kr127
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 200230.KQ
View MorePerformance Overview: 200230.KQ
Trailing total returns as of 2/24/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 200230.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 200230.KQ
View MoreValuation Measures
Market Cap
49.12B
Enterprise Value
85.58B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.33
Price/Book (mrq)
0.52
Enterprise Value/Revenue
2.32
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-27.19%
Return on Assets (ttm)
-0.32%
Return on Equity (ttm)
-10.43%
Revenue (ttm)
36.95B
Net Income Avi to Common (ttm)
-10.05B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
6.45B
Total Debt/Equity (mrq)
44.91%
Levered Free Cash Flow (ttm)
8.86B